| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 11/30/2005 | CN1703505A A method of treating an autoimmune disease |
| 11/30/2005 | CN1703504A Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes in mature dendritic cells in vivo$ |
| 11/30/2005 | CN1703420A Promoters exhibiting endothelial cell specificity and methods of using same |
| 11/30/2005 | CN1703247A Anti-neovasculature preparations for cancer |
| 11/30/2005 | CN1703175A Implantation of encapsulated biological materials for treating diseases |
| 11/30/2005 | CN1701814A F1K-1 is a receptor for vascular endothelial growth factor |
| 11/30/2005 | CN1229499C Phosphodiesterase 8A |
| 11/30/2005 | CN1229498C Recombinant ribonuclease proteins |
| 11/30/2005 | CN1229496C Method and compositions for inducing tumor-specific cytotoxicity |
| 11/30/2005 | CN1229493C Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene |
| 11/30/2005 | CN1229385C Composition for stimulating megacaryocyte growth and differentiation and process thereof |
| 11/29/2005 | US6969790 Inbred corn line PHB1V |
| 11/29/2005 | US6969789 containing in its genetic material one or more transgenes that confer disease resistance, herbicide resistance, insect resistance, or altered phytate content or metabolic activity; made by crossing two proprietary inbred lines |
| 11/29/2005 | US6969788 Inbred maize line PHBAB |
| 11/29/2005 | US6969786 Canola line 43A56 |
| 11/29/2005 | US6969760 Jak kinases and regulation of cytokine signal transduction |
| 11/29/2005 | US6969608 Pharmaceuticals containing multipotential precursor cells from tissues containing sensory receptors |
| 11/29/2005 | US6969600 Stereoselectivity; capable of acting on a substrate, 4-haloacetoaectate ester, to produce optically active (S)-4-halo-3-hydroxybutyrate ester with high optical purity at a high yield |
| 11/29/2005 | US6969598 Methods for producing high titre vectors and compositions used in such methods |
| 11/29/2005 | US6969597 Nucleic acids encoding non aggregating fluorescent proteins and methods for using the same |
| 11/29/2005 | US6969523 Collagen/glycosaminoglycan matrix stable to sterilizing by electron beam radiation |
| 11/29/2005 | CA2118329C Isolation, characterization, and use of the human .beta. subunit of the high affinity receptor for immunoglobulin e |
| 11/26/2005 | CA2503095A1 Use of lif in cell and tissue engineering |
| 11/24/2005 | WO2005111228A1 Method of assaying substance capable of changing mitochondrial membrane potential |
| 11/24/2005 | WO2005111221A1 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 11/24/2005 | WO2005111213A1 Target gene mimitin of myc |
| 11/24/2005 | WO2005111208A1 Method of proliferating plasma cell |
| 11/24/2005 | WO2005111198A1 Cancerous disease modifying antibodies |
| 11/24/2005 | WO2005111197A1 Method of forming mesenchymal stem cells from embryonic stem cells |
| 11/24/2005 | WO2005111121A2 Method for producing shaped bodies made from crosslinked gelatine |
| 11/24/2005 | WO2005111069A2 Morphogenic proteins and stimulatory factors in gene therapy |
| 11/24/2005 | WO2005111068A2 A method for purifying and recovering silk proteins using magnetic affinity separation |
| 11/24/2005 | WO2005111067A1 A novel identified oncogene with kinase-domain (nok) |
| 11/24/2005 | WO2005110491A2 Inducible dimerization of growth factor receptors for treating cancer |
| 11/24/2005 | WO2005110433A1 Nonhuman animal having expression of bach2 artificially inhibited, and use thereof |
| 11/24/2005 | WO2005080431A3 Monoclonal antibodies that specifically bind to folate receptor alpha |
| 11/24/2005 | WO2005079267A3 Methods for protein production |
| 11/24/2005 | WO2005065354A3 Defined media for pluripotent stem cell culture |
| 11/24/2005 | WO2005063961A3 Electrofusion chamber and method for the quantification of hybridoma yields |
| 11/24/2005 | WO2005049795A3 Mammalian cell lines for detecting, monitoring, and optimizing oligonucleotide-mediated chromosomal sequence alteration |
| 11/24/2005 | WO2005030145A3 Composition and pharmacology of novel alpha-6-containing nicotinic acetylcholine receptors |
| 11/24/2005 | WO2005017131A3 Methods for the differentiation of human stem cells |
| 11/24/2005 | WO2005002499A3 A method and therapeutic platelets |
| 11/24/2005 | WO2004103271A3 Disease prevention and vaccination prior to thymic reactivations |
| 11/24/2005 | WO2004091525A3 Morpholino imaging and therapy via amplification targeting |
| 11/24/2005 | US20050262596 Embryo preferred promoter and method of using same |
| 11/24/2005 | US20050262589 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 11/24/2005 | US20050262588 Thioesterase-related nucleic acid sequences and methods of use for the production of plants with modified fatty acid composition |
| 11/24/2005 | US20050262587 Novel Bt toxin receptors from lepidopteran insects and methods of use |
| 11/24/2005 | US20050262583 Clubroot resistant brassica oleracea plants |
| 11/24/2005 | US20050262581 System and sequential culture media for in vitro fertilization |
| 11/24/2005 | US20050262580 Transgenic mouse with a targeted deletion of Elovl4 gene |
| 11/24/2005 | US20050261489 Immune system disorders, cancer, viral diseases |
| 11/24/2005 | US20050261487 Dna molecules encoding ligand-gated ion channels from drosophila melanogaster |
| 11/24/2005 | US20050261479 Method for purifying and recovering silk proteins using magnetic affinity separation |
| 11/24/2005 | US20050261478 For activating T and/or B cells by aggregating three or more cell surface antigens; the activation signals may result in either immune enhancement or immunosuppression |
| 11/24/2005 | US20050261234 GFAP-based gene therapy for treatment of retinal diseases |
| 11/24/2005 | US20050261212 RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering RNA |
| 11/24/2005 | US20050261189 Methods of promoting cardiac cell proliferation |
| 11/24/2005 | US20050261186 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 11/24/2005 | US20050261183 PTHrP-derived modulators of smooth muscle proliferation |
| 11/24/2005 | US20050261175 monoclonal antibody immunoreactive with a stem cell factor; hybridoma cell line; can stimulate growth of primitive progenitors including early hematopoietic progenitor cells |
| 11/24/2005 | US20050260758 High efficiency peptide production in plant cells |
| 11/24/2005 | US20050260753 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 11/24/2005 | US20050260752 Culture medium containing enhancers of oxidative phosphorylation |
| 11/24/2005 | US20050260751 Pluripotent adult stem cells |
| 11/24/2005 | US20050260750 Process for obtaining mammalian insulin secreting cells in vitro and their uses |
| 11/24/2005 | US20050260749 Differentiation of stem cells to endoderm and pancreatic lineage |
| 11/24/2005 | US20050260748 Adult stem cells and uses thereof |
| 11/24/2005 | US20050260747 Embryonic stem cells and neural progenitor cells derived therefrom |
| 11/24/2005 | US20050260743 Smart cell culture |
| 11/24/2005 | US20050260734 Packaging cells |
| 11/24/2005 | US20050260732 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators |
| 11/24/2005 | US20050260714 Novel compounds |
| 11/24/2005 | US20050260713 Polypeptides and nucleic acids encoding same |
| 11/24/2005 | US20050260711 Modulating pH-sensitive binding using non-natural amino acids |
| 11/24/2005 | US20050260708 Proteases and protease inhibitors |
| 11/24/2005 | US20050260707 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 11/24/2005 | US20050260693 Tumor suppressor gene |
| 11/24/2005 | US20050260690 Methods and materials for diagnosing unstable angina |
| 11/24/2005 | US20050260688 Methods and compositions for hair growth |
| 11/24/2005 | US20050260675 Useful in identifying and designing novel Bt toxin receptor ligands including novel insecticidal toxins; manipulating Bt toxin susceptibility in plant pests |
| 11/24/2005 | US20050260670 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 11/24/2005 | US20050260668 Novel compounds |
| 11/24/2005 | US20050260667 determining the predisposition of individuals to schizophrenia, bipolar disorder and mental disorders; drug screening; reduced side effects |
| 11/24/2005 | US20050260657 Molecular entity for controlling a calcium |
| 11/24/2005 | US20050260644 Cell signaling proteins |
| 11/24/2005 | US20050260632 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/24/2005 | US20050260623 Oct-4 and GJIC expression as markers for adult human stem cells and cancer cell precursors |
| 11/24/2005 | US20050260622 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/24/2005 | US20050260617 Oligo-or polynucleotides |
| 11/24/2005 | US20050260616 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 11/24/2005 | US20050260599 Nucleic acid and amino acid sequences of sweet taste receptors comprising two heterologous G-protein coupled receptor polypeptides; screening for modulators; probes for the identification of taste cells |
| 11/24/2005 | US20050260597 Transfection reagents |
| 11/24/2005 | US20050260596 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 11/24/2005 | US20050260585 Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms |
| 11/24/2005 | US20050260576 Recombinantly expressed and isolated human SCN1A polypeptide and a modified human SCN1A nucleic acid that encodes it; producing an antibody that specifically binds a sodium channel; detecting and/or identifying a sodium channel polypeptide; anticonvulsants, neuroprotective agents and analgesics |
| 11/24/2005 | US20050260575 Method for identifying substances useful for treating inflammation using the response element to the ikbalpha ror receptor |
| 11/24/2005 | US20050260565 contacting in vitro a sample comprising chemokine 88C receptor with a putative ligand, detecting binding of the 88C receptor and the putative ligand; increase in 88C signal transduction activity indicates the ligand is an activator, a decreasein transduction activity indicates the ligand is an inhibitor |
| 11/24/2005 | US20050260234 Anti-neovasculature preparations for cancer |